Where does Bioserenity rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Bioserenity ranks #28,260 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Bioserenity hold?

Bioserenity holds 9 US utility patents granted between 2020 and 2023, spanning 8 technology areas.

What is Bioserenity's Innovation Score?

Bioserenity has an Innovation Score of 27.9 out of 100 (25th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Bioserenity focus on?

Bioserenity's top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 4 patents, ranking #3,645 of 7,127 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

Is Bioserenity's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Bioserenity.

What does claim depth mean for Bioserenity's patents?

Bioserenity's patents average 7.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Bioserenity patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Bioserenity

USPTO PatentsView assignee record - 9 granted patents across 8 technology areas, recorded in grant years 2020–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Bioserenity ranks #28,260 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 8 technology areas.

#28,260
of 49,997 US assignees by volume: 25th percentile
by Innovation Score (27.9/100): 7.8
avg claims per patent

USPTO PatentsView assignee plate

Corpus R28260 · Foreign Corporation #28,260 · 9 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-SPARSE · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 9 grants
MID-PACK #28,260/49,997
PHOTO-FINISH BioLegend
CPC-NARROW A61B · 8 areas
INNOV-THIN 27.9/100
CLAIMS-SPARSE 7.8 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2020–2023 · 4y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: BioLegend, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Bioserenity’s 27.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.0 pts (29%) Velocity 5.3 pts (19%) Breadth 10.0 pts (36%) Claim depth 4.7 pts (17%)

Qualcomm Incorporated · highest

85
Bioserenity · this assignee

28
3D Lighting… · lowest

7

What this shows Bioserenity's Innovation Score is 27.9/100 (25th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Bioserenity?

Each dot is one of Bioserenity’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Bioserenity’s own 7.8 claims/patent is at or below the 17.0 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Bioserenity vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Bioserenity's grants concentrate

Bioserenity is a focused PatentsView assignee: 8 CPC subclasses with 44.4% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2020 (3 grants) versus a trough of 1 in 2022. By volume, Bioserenity sits between BioLegend, Inc. and Bison Gear & Engineering Corp..

Bioserenity's three-year grant acceleration

Bioserenity shows 4 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Biolegend

9
Biopharmx

9
Biomet Microfixat…

9
Bioness Neuromodu…

9
Biotie Therapies

9
Bird Home Automat…

9
Biscom

9
Bison Gear & Engi…

9
Bioserenity ◀

9

What this shows Bioserenity holds 9 patents at rank #28,284, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Bioserenity

By rank, the assignees closest to #28,284 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Bioserenity's primary technology class.

Bioserenity's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

28 25th percentile higher than 25% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

Bioserenity patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	3	33.3%
2021	2	22.2%
2022	1	11.1%
2023	3	33.3%

Which technologies does Bioserenity patent most?

A61B - DIAGNOSIS; SURGERY; Identification 4

H01R - Electrically-conductive CONNECTIONS; Structural Associations OF A Plurality OF Mutually-insulated Electrical Connecting ELEMENTS; Coupling DEVICES; Current Collectors 2

D02G - Crimping OR Curling Fibres, Filaments, Threads, OR YARNS; Yarns OR Threads 2

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 2

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 1

D10B - Indexing Scheme Associated With Sublasses OF Section D, Relating TO Textiles 1

B32B - Layered Products, i.e. Products Built-up OF Strata OF Flat OR Non-flat, e.g. Cellular OR Honeycomb, Form 1

H05K - Printed CIRCUITS; Casings OR Constructional Details OF Electric APPARATUS; Manufacture OF Assemblages OF Electrical Components 1

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Bioserenity's patent record in context - here's where to go next.

Bioserenity's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 44.4% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #28,260 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Bioserenity against BioLegend, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 27.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.